logo

SLN

Silence Therapeutics·NASDAQ
--
--(--)
--
--(--)
5.67 / 10
Netural

Analyst sentiment is surprisingly positive—100% Strong Buy consensus from one active analyst—yet fund-flow data reveal a complex picture: small and medium inflows are positive while block, large, and extra-large flows are negative. The fund-flow score of 7.59/10 is good, indicating net inflow but with mixed size segments. This divergence suggests institutional skepticism despite bullish price targets, warranting vigilance for potential price pullbacks if larger funds exit.

FundamentalSentiment(5.67)Technical
Fund Flow Rating
Analyst RatingStrong Buy

Wall Street Opinions

Strong Buy

Strong Buy

100%

Buy

0%

Hold

0%

Sell

0%

Strong Sell

0%

Date2025-09-16
InstitutionHC Wainwright & Co.
Times predicted1
Historical Win Rate100.0%
What is the analyst consensus for SLN?
  • SLN holds a Bearish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 5.67/10 (Netural).